MedX Health (CVE:MDX) Sets New 1-Year High at $0.10

MedX Health Corp (CVE:MDX)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as C$0.10 and last traded at C$0.10, with a volume of 41500 shares traded. The stock had previously closed at C$0.09.

MedX Health Trading Up 11.1 %

The company’s 50 day moving average is C$0.06 and its 200 day moving average is C$0.06. The stock has a market capitalization of C$26.20 million, a price-to-earnings ratio of -3.33 and a beta of 1.21.

MedX Health (CVE:MDX) last announced its quarterly earnings results on Wednesday, March 6th. The company reported C($0.53) EPS for the quarter. The company had revenue of C$26.41 million for the quarter. Analysts anticipate that MedX Health Corp will post 0.0029191 EPS for the current fiscal year.

MedX Health Company Profile

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.